BASF to Develop a High Purity Poloxamer for Mast Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) | Delayed: 14.42 -1.33 (8.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.75 | 52 Week High | $0.71 | |||
| Open | $14.73 | 52 Week Low | $0.07 | |||
| Day High | $15.44 | P/E | N/A | |||
| Day Low | $13.85 | EPS | $-0.35 | |||
| Volume | 5,436,274 | |||||
| MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) | Delayed: 14.42 -1.33 (8.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.75 | 52 Week High | $0.71 | |||
| Open | $14.73 | 52 Week Low | $0.07 | |||
| Day High | $15.44 | P/E | N/A | |||
| Day Low | $13.85 | EPS | $-0.35 | |||
| Volume | 5,436,274 | |||||
